Potential Policy Changes that Could Upend Prescription Drug Pricing

On November 3, 2021, Congress introduced a working draft of the Build Back Better (BBB) ​​Act. This legislation includes proposals that could drive some of the most material changes in drug pricing in the history of the Medicare Parts B and D programs. The changes are sweeping, with potential for some—such as inflation rebates—to be … Read more